Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.

This New Jersey bill requires pharmacy benefits managers (PBMs) to disclose pricing methodologies in contracts, including whether they use different pricing lists for retail versus mail-order drugs, and to provide a toll-free line for consumers to speak with a New Jersey-licensed pharmacist about drug pricing issues within 24 hours. It establishes a Prescription Drug Review Commission to identify critical prescription drugs (based on factors like cost to public health programs and treatment effectiveness) and monitor their pricing. These measures aim to increase transparency in drug pricing and reduce costs for essential medications, directly affecting PBMs and the state's Division of Consumer Affairs.